Skip to main content

Peer Review reports

From: Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer

Original Submission
25 Jan 2019 Submitted Original manuscript
11 Feb 2019 Author responded Author comments - Tsutomu Iwasa
Resubmission - Version 2
11 Feb 2019 Submitted Manuscript version 2
10 Sep 2019 Author responded Author comments - Tsutomu Iwasa
24 Mar 2019 Reviewed Reviewer Report - Luca Moscetti
22 Aug 2019 Reviewed Reviewer Report - Eva Blondeaux
Resubmission - Version 3
10 Sep 2019 Submitted Manuscript version 3
Publishing
24 Sep 2019 Editorially accepted
16 Oct 2019 Article published 10.1186/s12885-019-6200-5

You can find further information about peer review here.

Back to article page
\